Study guide

2.2 Acute Kidney Injury & Chronic Kidney Disease Staging

BONENT Certified Hemodialysis Nurse CHN

Track your progress as you read

Finished sections get a check mark.

1 Exam Orientation

1.1 Current CHN Exam Facts and Study Strategy

2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology

2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD

3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations

3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management

4 Individualized Nursing Care

4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral

5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry

5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR

6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters

6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention

7 Chapter 5: Cannulation Practice & Access Complications

7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management

8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring

8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment

9 Equipment and Laboratory Skills

9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results

10 Chapter 7: Acute Intradialytic Complications & Emergencies

10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss

11 Extended and Acute Treatment

11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation

12 Chapter 8: Nephrology Pharmacology in Hemodialysis

12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing

13 Home and Peritoneal Dialysis

13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care

14 Kidney Transplantation

14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes

15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing

15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety

16 Clinical Unit Management

16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care

17 Chapter 10: Supervision, Administration & Professional Practice

17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care

18 Professional Development

18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation

19 Environmental Hazards and Emergency Planning

19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions

2.2 Acute Kidney Injury & Chronic Kidney Disease Staging

Key Takeaways Explain This Topic AI

KDIGO AKI criteria use creatinine change and urine-output duration.

Prerenal, intrinsic and postrenal categories guide evaluation, but urine indices alone do not diagnose the cause.

CKD requires persistent abnormalities for at least three months and is classified by cause, GFR and albuminuria.

Urgent dialysis decisions consider refractory disturbances, symptoms and the clinical course rather than one universal numerical threshold.

Last updated: October 2026

Acute Kidney Injury & Chronic Kidney Disease Staging

Renal failure spans a spectrum from acute, reversible declines in excretory function to permanent parenchymal destruction culminating in end-stage renal disease (ESRD). Distinguishing acute kidney injury (AKI) from chronic kidney disease (CKD)—and recognizing acute insults superimposed on chronic impairment—is critical for tailoring dialytic intensity, planning vascular access, and avoiding fatal complications.

Acute Kidney Injury: KDIGO Criteria & Staging

Acute Kidney Injury (AKI) is an abrupt decline in glomerular filtration resulting in azotemia and fluid-electrolyte dysregulation. The Kidney Disease: Improving Global Outcomes (KDIGO) criteria define AKI by any one of three parameters:

Serum creatinine increase by ≥ 0.3 mg/dL \ge 0.3\text{ mg/dL} ≥ 0.3 mg/dL within 48 hours ; OR

Serum creatinine increase to ≥ 1.5 × baseline \ge 1.5\times\text{ baseline} ≥ 1.5 × baseline within the prior 7 days ; OR

Documented urine output < 0.5 mL/kg/h < 0.5\text{ mL/kg/h} < 0.5 mL/kg/h for 6 consecutive hours .

Stage Serum Creatinine Criteria Urine Output Criteria

Stage 1 1.5 – 1.9 × 1.5–1.9\times 1.5–1.9 × baseline OR increase ≥ 0.3 mg/dL \ge 0.3\text{ mg/dL} ≥ 0.3 mg/dL < 0.5 mL/kg/h < 0.5\text{ mL/kg/h} < 0.5 mL/kg/h for 6–12 h

Stage 2 2.0 – 2.9 × 2.0–2.9\times 2.0–2.9 × baseline < 0.5 mL/kg/h < 0.5\text{ mL/kg/h} < 0.5 mL/kg/h for ≥ 12 \ge 12 ≥ 12 h

Stage 3 ≥ 3.0 × \ge 3.0\times ≥ 3.0 × baseline OR creatinine ≥ 4.0 mg/dL \ge 4.0\text{ mg/dL} ≥ 4.0 mg/dL OR renal replacement therapy < 0.3 mL/kg/h < 0.3\text{ mL/kg/h} < 0.3 mL/kg/h for ≥ 24 \ge 24 ≥ 24 h OR anuria for ≥ 12 \ge 12 ≥ 12 h

AKI Classification: Prerenal, Intrinsic, and Postrenal

AKI is classified clinically into three anatomical categories:

1. Prerenal Azotemia

Prerenal AKI reflects reduced renal perfusion, often from volume loss, reduced effective arterial volume or vascular factors. Urine indices can support assessment but cannot establish the cause independently.

2. Intrinsic (Intrarenal) AKI

Intrinsic AKI reflects injury to renal tissue, including tubular, interstitial, glomerular or vascular disease.

Acute tubular injury: Ischemia and nephrotoxic exposure can injure tubular cells. Granular casts support the diagnosis, but FeNa, urine concentration and BUN/creatinine ratios vary with context.

Acute Interstitial Nephritis (AIN) : Drug-induced allergic inflammation (beta-lactams, PPIs, NSAIDs) which may produce pyuria or white-cell casts. Urine eosinophils are neither sensitive nor specific enough to confirm the diagnosis.

Acute Glomerulonephritis (AGN) : Inflammatory injury with hematuria, dysmorphic RBCs, RBC casts , and proteinuria.

3. Postrenal (Obstructive) AKI

Results from urinary outflow obstruction (BPH, malignancy, stones, blocked catheter). Retrograde hydrostatic pressure transmits into Bowman's space, opposing filtration. Imaging helps evaluate obstruction, although early obstruction may not produce obvious hydronephrosis. Prompt decompression can improve function; recovery depends on the cause and duration.

Diagnostic Parameter Prerenal Azotemia Intrinsic Acute Tubular Necrosis (ATN)

BUN:Creatinine Ratio > 20 : 1 > 20:1 > 20 : 1 (avid urea reabsorption) < 15 : 1 < 15:1 < 15 : 1 (impaired reabsorption)

Fractional Excretion of Na (FeNa) < 1.0 % < 1.0\% < 1.0% > 2.0 % > 2.0\% > 2.0%

Specific Gravity / Osmolality > 1.020 > 1.020 > 1.020 / > 500 mOsm/kg > 500\text{ mOsm/kg} > 500 mOsm/kg ≈ 1.010 \approx 1.010 ≈ 1.010 (isosthenuric) / < 350 mOsm/kg < 350\text{ mOsm/kg} < 350 mOsm/kg

  • Urine Microscopic Sediment Bland, hyaline casts Muddy brown granular casts , RTE cells
  • Chronic Kidney Disease: KDIGO 2024 Staging

Chronic Kidney Disease (CKD) is structural or functional kidney damage persisting at least three months .

KDIGO Staging Matrix (CGA Classification)

GFR Categories (mL/min/1.73 m²) : G1 : ≥ 90 \ge 90 ≥ 90 (normal/high); G2 : 60 – 89 60–89 60–89 (mild); G3a : 45 – 59 45–59 45–59 (mild-moderate); G3b : 30 – 44 30–44 30–44 (moderate-severe); G4 : 15 – 29 15–29 15–29 (severely decreased); G5 : < 15 < 15 < 15 (kidney failure/ESRD).

Planning in advanced CKD: Teach modality options, preserve suitable veins and arrange individualized access evaluation based on kidney-failure risk and the patient’s ESKD Life-Plan. Fistula maturation varies; neither a GFR category nor elapsed weeks alone establishes readiness for cannulation.

Albuminuria (UACR) : A1 : < 30 mg/g < 30\text{ mg/g} < 30 mg/g (mild); A2 : 30 – 300 mg/g 30–300\text{ mg/g} 30–300 mg/g (moderate); A3 : > 300 mg/g > 300\text{ mg/g} > 300 mg/g (severe macroalbuminuria).

The CKD-EPI 2021 race-free equation eliminates race multipliers from eGFR calculation, ensuring equitable care and transplant waitlisting.

Leading Etiologies of Kidney Failure

Diabetes and hypertension are common causes of chronic kidney disease, but the nurse must also recognize glomerular disease, inherited disorders such as autosomal dominant polycystic kidney disease, chronic obstruction, recurrent infection, and drug or toxin injury. Diabetes produces albuminuria and progressive nephron loss; hypertension can be both a cause and a consequence of renal disease. Hematuria with active sediment suggests a different investigation from isolated longstanding albuminuria. Family history, prior creatinine measurements, medication exposure and imaging help distinguish chronic disease from a reversible acute component.

Fractional excretion indices are supporting data rather than diagnostic verdicts. Diuretics can raise fractional sodium excretion; fractional urea excretion is also affected by illness, sepsis and timing. Neither a low nor high value replaces examination, urine microscopy, obstruction assessment or response to treatment. Anuria with a distended bladder requires prompt obstruction evaluation, not automatic classification as irreversible kidney failure.

Progressive G4 disease warrants education about hemodialysis, peritoneal dialysis, transplantation and conservative care. Access planning follows the individual’s kidney-failure risk, vessel anatomy, expected course and treatment preferences. It does not require every G4 patient to undergo fistula surgery on the same timetable. Protect suitable veins while the nephrology and access teams develop the patient’s ESKD Life-Plan.

Indications for Urgent Kidney Replacement Therapy

The mnemonic AEIOU organizes indications: refractory acidosis , dangerous electrolyte disturbance, selected dialyzable intoxications , refractory fluid overload , and symptomatic uremia . It is a reasoning aid, not a set of universal laboratory orders. Severe hyperkalemia with ECG changes requires immediate stabilization while arranging definitive potassium removal. Pulmonary edema despite appropriate medical therapy, uremic encephalopathy, pericarditis and some toxic exposures may justify urgent therapy.

Decisions consider the whole clinical picture, laboratory trends and available treatment. A potassium result, BUN value or pH alone is not an automatic universal dialysis threshold. Suspected poisoning requires poison-control/toxicology consultation because dialyzability and treatment indications differ between agents. Rising BUN without symptoms is evaluated differently from a patient with seizures or a pericardial rub. Once urgent dialysis is ordered, verify the prescription, access, anticoagulation plan and monitoring intensity rather than accelerating clearance without an order.

Sources checked 2026-10-10: KDIGO CKD and AKI